1Tsutamoto T,Wada A, Maeda K, et al. Attention of compensation of endogenous cardiac natriuretic peptides system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction. Circulation, 1997,96:509-516.
2CHen HH, Burent JC, Natriuretic peptide in the pathophysiology of congestive heart failure. Curt Cardiol Rep,2000,2:198-205.
3石林,李俊成,秦晓群.临床生理学.第1版,北京:科学出版社,2001.187-188.
4Tamura N, Ogawa Y, Yasoda A, et al. J Mol Cell Cardiol, 1996,28 :1811-1815.
5Sudoh T, Minamino N, et al. C-type natriuretic peptide (CNP) :a new member of the natriuretic peptide family identified in porcine brain. Biophs Res Commun, 1990,168:863-870.
6Lainchbury JG, Nicolls MG, Espiner EA, et al. Regional plasma levels of cardiac peptides and their response to acute neutral cndopeptidase inhibition in man. Clin Sci, 1998,95:547-555.
7Alan,Maisel et al. B-type Natriuretic peptides levels: a potential novel "white count" for congestive heart failure. Journal of cardiac failure, 2001,7 : 183.
8Yoshizomi M, Tsuji H, Nishimura H, Natriuretic peptide regulate the expression of tissue factor and PAI-1 in endothelial cells. Thromb Haemost, 1999,82 : 1497-1503.
9Leroy C, Uzan L, Bugugnani M J, et al. The Value repeated deter-minationv of brain natnrretic peptide for the diagnosis of unstable anginal, Arch Coeur Vaiss ,2003,96 : 305-310.
10Morrison LK, Hanson A, Krishnaswamy P, et al. Utility of a rapid B-natriuretic peptide assay in differentiating congestive heart failure form lung diease in patients presenting with dyspnea. J An Coll Cardiol, 2002,39 : 202 -209.
3[1]Sudoh T,Kangawa K,Minamino N,et al.A new natriuretic peptide in porcine[J].Nature,1988,332(1):78-81.
4[4]Cargill R I,Lipworth B J.Pulmonary vasorelaxant activity of atrial natriuretic peptide and brain natriuretic peptide in humans[J].Thorax,1995,50(1):183-185.
5[5]Cargill R I,Lipworth B J.Acute effects of ANP and BNP on hypoxic pulmonary vasoconstriction in humans[J].Br J Clin Pharmcol,1995,40:585-590.
7Hofbauer K H,Jensen B L,Kurtz A,et al.Tissue poxygengnation activates the adrenomedullin insystem in vivol[J].Am J Physiol Regu Integr Comp Physiol,2000,278:R513-519.
8Ehlenz K,Koch B,Preuss P,et al.High levels of circulating adrenomedullin in severe illness:correlation with C reactive protein and evidence against the adrenomedulla as site of origin[J].Exp Clin Endocrinol Diabetes,1997,105:156-162.
9Sugos S,Minamino N,Shoji H,et al.Effects of vasoactive substance and CAMP related compounds on adrenomedullin production in cultured vascular smooth muscle cells[J].FEBS Lett,1995,369:311-314.
10Yoshibara F,Nishikimi K,Horio T,et al.Chronic infusion of adrenomedullin reduces pulmonary hypertention and lessens right ventuicular hypertrophy in rats administered monocrotaline[J].Eur J Pharmacol,1998,355:33-39.
